Blood Cancer Journal· 2016Q1· Review
‘Acute myeloid leukemia: a comprehensive review and 2016 update’
- 1,351citations
- Q1SCImago
- 2016year
Short summary
Recurrent genetic mutations like FLT3-ITD, NMP1, and CEBPA refine prognosis and guide treatment for acute myeloid leukemia (AML), a heterogeneous disease affecting over 20,000 US cases annually.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Hematology
HematologyMedicine